Get the latest tech news
FastWave Medical: A promising intravascular lithotripsy (IVL) startup in an $8.5 billion cardiovascular market
Contributor Content In cardiovascular healthcare, innovation can mean the difference between life and death. FastWave Medical is at the forefront of this innovation, designing and developing novel intravascular lithotripsy (IVL) systems led by a fast-moving team dedicated to pioneering solutions for calcific artery disease. With a market valued at over $8 billion, the opportunities for growth and […]
FastWave Medical is at the forefront of this innovation, designing and developing novel intravascular lithotripsy (IVL) systems led by a fast-moving team dedicated to pioneering solutions for calcific artery disease. The association of coronary artery calcium, with major risk factors such as advancing age, diabetes, renal failure and hypertension, underscores the need for comprehensive evaluation and innovative management strategies in cardiovascular care. Dr. Arthur Lee, an interventional cardiologist at The Cardiac and Vascular Institute in Gainesville, FL, said, “It’s remarkable how quickly IVL has become a staple in the arsenal for managing calcific disease in both coronary arteries and lower extremities.
Or read this on Venture Beat